What is the abbreviation for cycloserine?

Cycloserine (Cycloserine) is an important drug for the treatment of tuberculosis and partially drug-resistant infections. It has a long history of use internationally and its English abbreviation is usually DCS. This abbreviation is frequently cited in global medical literature, clinical guidelines, anti-tuberculosis drug classifications, and the World Health Organization's drug-resistant tuberculosis treatment protocols. For patients or medical staff who need to consult overseas information or read English instructions, it is necessary to master this abbreviation, because many professional documents do not repeat the full name, but directly use the "DCS" logo.

The use of DCS is not only a naming abbreviation, but also a confirmation of the positioning of cycloserine in the anti-tuberculosis drug system. Cycloserine is classified as one of the important alternative drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB). In order to make it easier to use in drug combination regimens, dose adjustments, and toxicity analysis reports, scientific researchers generally use the abbreviation format, so "Cycloserine = DCS" has almost become a global standard.

In addition, in the field of drug supervision, includingFDA, EMA and WHO-related documents, as long as drug-resistant tuberculosis treatment is involved, the drug table will almost always be displayed with "DCS", which is very important for reading policy guidelines or academic research. If you see DCS when reading anti-infective drug research data, resistance pattern analysis, or adverse drug reaction statistics, you can basically directly understand it as cycloserine.

It is worth noting that the trade names (such as datraZeneca, etc.) may differ in different countries, but the international abbreviation DCS has never changed. For patients who need to purchase overseas versions or inquire about overseas prices and specifications, knowing the abbreviations can avoid misunderstandings due to brand differences. For example, in some countries, cycloserine will be marketed under different trade names, but "Cycloserine (DCS)" will still be marked on the English packaging to ensure that medical staff will not be confused when reviewing cross-border prescriptions.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine